Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 6NIH 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Smoldering Multiple Myeloma 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Burkitt Lymphoma 1

Interventions

Specimen Handling 318Magnetic Resonance Spectroscopy 215Biopsy 183Nivolumab 49X-Rays 43Radiation 42Immunoglobulin G 41Disulfides 41Paclitaxel 40Taxes 39Cisplatin 39pembrolizumab 38Cyclophosphamide 38Platinum 371,2-diaminocyclohexaneplatinum II citrate 37Carboplatin 35Radiotherapy 33atezolizumab 30Doxorubicin 30venetoclax 24olaparib 24Ipilimumab 24Gemcitabine 24CTLA-4 Antigen 24Bevacizumab 24Prednisone 21cabozantinib 20Vincristine 20Phantoms, Imaging 19Etoposide 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Peripheral Blood Stem Cell Transplantation × 30 days × Clear all
NCT00114101 2026-05-29

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

National Cancer Institute (NCI)

Phase 3 Active not recruiting
460 enrolled 11 charts
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT00792948 2026-05-29

Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
97 enrolled 7 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡